End-of-life care in patients with implantable cardioverter defibrillators: A MADIT-II substudy

PACE - Pacing and Clinical Electrophysiology

Volumn 36, Issue 10, 2013, Pages 1273-1279

  Sherazi, Saadia ^a   McNitt, Scott ^a   Aktas, Mehmet K ^a   Polonsky, Bronislava ^a   Shah, Abrar H ^a   Moss, Arthur J ^a   Daubert, James P ^b   Zareba, Wojciech ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

end of life: ICD and deactivation

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CONVULSIVE THERAPY; DETERIORATION; DYSPNEA; FAINTNESS; FEMALE; HEART DEATH; HEART PALPITATION; HOSPICE CARE; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; PRESYNCOPE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TERMINAL CARE;

END OF LIFE: ICD AND DEACTIVATION;

AGED; AGED, 80 AND OVER; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC INJURIES; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSTHESIS FAILURE; RISK ASSESSMENT; SURVIVAL RATE; TERMINAL CARE; UNITED STATES;

EID: 84886413078     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12188     Document Type: Article

References (17)

1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, et al.; Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1933-1940.
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G,; Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999; 341: 1882-1890.
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
5. Mark DB, Anstrom KJ, Sun JL, Clapp-Channing NE, Tsiatis AA, Davidson-Ray L, Lee KL, et al. Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med 2008; 359: 999-1008.
6. Irvine J, Dorian P, Baker B, O'Brien BJ, Roberts R, Gent M, Newman D, et al. Quality of life in the Canadian implantable defibrillator study (CIDS). Am Heart J 2002; 144: 282-289.
7. Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM,. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med 2004; 141: 835-838.
8. Lewis WR, Luebke DL, Johnson NJ, Harrington MD, Costantini O, Aulisio MP,. Withdrawing implantable defibrillator shock therapy in terminally ill patients. Am J Med 2006; 119: 892-896.
9. Mueller PS, Hook CC, Hayes DL,. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life. Mayo Clin Proc 2003; 78: 959-963.
10. Kapa S, Mueller PS, Hayes DL, Asirvatham SJ,. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: Results of a survey of medical and legal professionals and patients. Mayo Clin Proc 2010; 85: 981-990.
11. Wright AA, Zhang B, Ray A, Mack JW, Trice E, Balboni T, Mitchell SL, et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 2008; 300: 1665-1673.
12. Sears SF, Sowell LV, Kuhl EA, Handberg EM, Kron J, Aranda JM Jr, Conti JB,. Quality of death: Implantable cardioverter defibrillators and proactive care. Pacing Clin Electrophysiol 2006; 29: 637-642.
13. Lampert R, Hayes DL, Annas GJ, Farley MA, Goldstein NE, Hamilton RM, Kay GN, et al. HRS expert consensus statement on the management of cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm 2010; 7: 1008-1026.
14. Mitar M, Alba AC, MacIver J, Ross H,. Lost in translation: Examining patient and physician perceptions of implantable cardioverter-defibrillator deactivation discussions. Circ Heart Fail 2012; 5: 660-666.
15. Sherazi S, Daubert JP, Block RC, Jeevanantham V, Abdel-Gadir K, DiSalle MR, Haley JM, et al. Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator. Mayo Clin Proc 2008; 83: 1139-1141.
16. Wilkoff BL, Auricchio A, Brugada J, Cowie M, Ellenbogen KA, Gillis AM, Hayes DL, et al. HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): Description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm 2008; 5: 907-925.
17. Fairman RP,. Withdrawing life-sustaining treatment. Lessons from Nancy Cruzan. Arch Intern Med 1992; 152: 25-27.